Likewise, AnxA2-mediated NFκB signaling contributed to tumourigenicity in xenograft models for glioblastoma multiforma (GBM) [158], with AnxA2 depletion strongly inhibiting GBM tumour growth and improving survival [159]. Here, ANXA2 is linked to neoplasm.